 | Up a level |
Journal Article
Kreuter, M., Bonella, F., Blank, N., Siegert, E., Henes, J., Worm, M., Sunderkoetter, C., Schmalzing, M., Kreuter, A., Guenther, C., Susok, L., Zeidler, G., Koetter, I, Mueller-Ladner, U., Krieg, T., Juche, A., Schmeiser, T., Riemekasten, G., Aberer, E., Gaebelein-Wissing, N., Distler, J. H. W., Sardy, M., Pfeiffer, C., Kuhr, K., Lorenz, H. M., Moinzadeh, P. and Hunzelmann, N. (2020). Does anti-acid treatment influence disease progression in SSc-ILD? Data form the German SSc-network. Pneumologie, 74. S. S55 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790
Kreuter, M., Bonella, F., Blank, N., Siegert, E., Henes, J., Worm, M., Sunderkoetter, C., Schmalzing, M., Kreuter, A., Guenther, C., Susok, L., Zeidler, G., Koetter, I, Mueller-Ladner, U., Krieg, T., Juche, A., Schmeiser, T., Riemekasten, G., Aberer, E., Gaebelein-Wissing, N., Distler, J. H. W., Sardy, M., Pfeiffer, C., Kuhr, K., Lorenz, H. M., Moinzadeh, P. and Hunzelmann, N. (2020). Long term outcomes of immunmodulatory drugs in SSc-ILD - data rom the German SSc network. Pneumologie, 74. S. S55 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790
Kreuter, M., Bonella, F., Kathrin, K., Henes, J., Siegert, E., Riemekasten, G., Blank, N., Pfeiffer, C., Mueller-Ladner, U., Kreuter, A., Korsten, P., Juche, A., Schmalzing, M., Worm, M., Jandova, I., Susok, L., Schmeiser, T., Guenther, C., Keyszer, G., Ehrchen, J., Ramming, A., Koetter, I., Lorenz, H. M., Moinzadeh, P. and Hunzelmann, N. (2021). LONG-TERM OUTCOME OF SSC ASSOCIATED ILD: IMPROVED SURVIVAL IN PPI TREATED PATIENTS. Ann. Rheum. Dis., 80. S. 670 - 672. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Kreuter, M., Bonella, F., Riemekasten, G., Mueller-Ladner, U., Henes, J., Siegert, E., Guenther, C., Koetter, I., Blank, N., Pfeiffer, C., Schmalzing, M., Zeidler, G., Korsten, P., Susok, L., Juche, A., Worm, M., Jandova, I., Ehrchen, J., Sunderkoetter, C., Keyszer, G., Ramming, A., Schmeiser, T., Kreuter, A., Kuhr, K., Lorenz, H. M., Moinzadeh, P. and Hunzelmann, N. (2020). DOES ANTI-ACID TREATMENT INFLUENCE DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS INTERSTITIAL LUNG DISEASE (SSC-ILD)? DATA FROM THE GERMAN SSC-NETWORK. Ann. Rheum. Dis., 79. S. 1585 - 1586. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Moinzadeh, P., Aberer, E., Ahmadi-Simab, K., Blank, N., Distler, J. W., Fierlbeck, G., Genth, E., Guenther, C., Hein, R., Henes, J., Herich, L., Herrgott, I., Koetter, I., Kreuter, A., Krieg, T., Kuhr, K., Lorenz, H. M., Meier, F., Melchers, I., Mensing, H., Mueller-Ladner, U., Pfeiffer, C., Riemekasten, G., Sardy, M., Schmalzing, M., Sunderkoetter, C., Susok, L., Tarner, I. H., Vaith, P., Worm, M., Zeidler, G. and Hunzelmann, N. (2014). SSc-overlap syndromes: a distinct clinical subgroup with significant differences in disease progression compared to lSSc and dSSc patients. Data of the German Network for Systemic Scleroderma (DNSS). Exp. Dermatol., 23 (3). S. E13 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625